We are live on ! Find out more
EMN icon

Eastman Chemical

570 hedge funds and large institutions have $9.25B invested in Eastman Chemical in 2014 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 184 increasing their positions, 211 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 47

55% more call options, than puts

Call options by funds: $146M | Put options by funds: $94.2M

7% more funds holding

Funds holding: 533570 (+37)

1.51% more ownership

Funds ownership: 80.82%82.33% (+1.5%)

7% less capital invested

Capital invested by funds: $9.91B → $9.25B (-$658M)

13% less repeat investments, than reductions

Existing positions increased: 184 | Existing positions reduced: 211

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
570
Holders Change
+37
Holders Change %
+6.94%
% of All Funds
15.2%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
92
Increased
184
Reduced
211
Closed
47
Calls
$146M
Puts
$94.2M
Net Calls
+$51.6M
Net Calls Change
-$3.79M
Name Holding Trade Value Shares
Change
Change in
Stake
CIC
126
Cornercap Investment Counsel
Georgia
$8.59M -$159K -2,015 -2%
ACI
127
AMP Capital Investors
Australia
$8.17M +$2M +25,354 +31%
WCM
128
Wedge Capital Management
North Carolina
$7.69M +$457K +5,775 +6%
ARC
129
Absolute Return Capital
Massachusetts
$7.52M -$222K -2,814 -3%
Barclays
130
Barclays
United Kingdom
$7.29M +$2.38M +30,136 +45%
BNP Paribas Financial Markets
131
BNP Paribas Financial Markets
France
$7.2M +$2.23M +28,240 +42%
CCM
132
Cobalt Capital Management
New Jersey
$7.13M +$7.43M +94,000 New
AL
133
Airain Ltd
Guernsey
$6.97M +$3.8M +48,089 +110%
PCA
134
Personal Capital Advisors
California
$6.89M +$1.37M +17,351 +24%
MLICM
135
Metropolitan Life Insurance Company (MetLife)
New York
$6.83M +$117K +1,483 +2%
DM
136
Delphi Management
Massachusetts
$6.82M +$941K +11,897 +15%
DekaBank Deutsche Girozentrale
137
DekaBank Deutsche Girozentrale
Germany
$6.7M +$508K +6,427 +8%
AQR Capital Management
138
AQR Capital Management
Connecticut
$6.69M +$2.02M +25,545 +41%
NCCM
139
Nine Chapters Capital Management
New Jersey
$6.68M +$6.97M +88,100 New
BTS
140
BB&T Securities
Virginia
$6.66M -$555K -7,025 -44%
WA
141
Wasatch Advisors
Utah
$6.6M -$3.72M -47,009 -35%
HW
142
Hancock Whitney
Mississippi
$6.46M -$123K -1,558 -2%
First Trust Advisors
143
First Trust Advisors
Illinois
$6.43M -$14.1M -177,729 -68%
VRS
144
Virginia Retirement Systems
Virginia
$6.38M -$3.16K -40 -0%
QIM
145
Quest Investment Management
Oregon
$6.29M -$648K -8,200 -9%
TD Asset Management
146
TD Asset Management
Ontario, Canada
$6.21M +$1.2M +15,161 +23%
Citigroup
147
Citigroup
New York
$6.18M +$542K +6,857 +9%
PAMU
148
Pictet Asset Management (UK)
United Kingdom
$6.15M +$101K +1,282 +2%
Stifel Financial
149
Stifel Financial
Missouri
$5.96M +$1.02M +12,963 +20%
DCM
150
Dupont Capital Management
Delaware
$5.82M +$35.7K +451 +0.6%

EMN Hedge Fund Activity: Q4 2014 in Review

570 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Eastman Chemical (EMN) for Q4 2014, worth a combined $9.25B — down 6.6% from $9.91B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new EMN positions and 47 closed out — a net gain of 45 holders — while 184 added to existing stakes and 211 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $114M. The largest seller was Bank of New York Mellon, cutting an estimated $71.5M.

  • 570 institutional investors held Eastman Chemical (EMN) as of Q4 2014, up from 533 in Q3 2014.
  • Funds reported $9.25B of Eastman Chemical stock for Q4 2014, down 6.6% quarter-over-quarter.
  • 92 funds opened new Eastman Chemical positions in Q4 2014 and 47 closed out, a net change of +45 holders.
  • The largest Eastman Chemical buyer in Q4 2014 was VOYA Investment Management, an estimated $114M added.
  • The largest Eastman Chemical seller in Q4 2014 was Bank of New York Mellon, an estimated $71.5M sold.

Based on aggregated 13F filings for Q4 2014.